Retnla (Relmα/Fizz1) Suppresses Helminth-Induced Th2-Type Immunity
John Pesce(National Institute of Allergy and Infectious Diseases), Thomas A. Wynn(National Institute of Allergy and Infectious Diseases), Mark S. Wilson(Gene Therapy Laboratory), Robert W. Thompson(National Institutes of Health), Allen W. Cheever(Biomedical Research Institute), Margaret Mentink‐Kane(National Institutes of Health), Thirumalai R. Ramalingam(National Institutes of Health), Joseph F. Urban(Beltsville Human Nutrition Research Center)
Cited by 216
Related Papers
Type 2 immunity in tissue repair and fibrosis
|Nature reviews. Immunology|2017|1.1k
Pulmonary fibrosis: pathogenesis, etiology and regulation
|Mucosal Immunology|2009|834
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
|PLoS Pathogens|2009|808
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740